FindTrial
Sign In

Clinical value of hybrid iterative reconstruction technique in low dose CT angiography: A prospective study of feasibility and reliability

Clinical value of hybrid iterative reconstruction technique in low dose CT angiography: A prospective study of feasibility and reliability

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-13004582
Enrollment
Unknown
Registered
2013-10-10
Start date
2014-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low dose CT angiography research

Interventions

Gold Standard:
Index test:

Sponsors

Capital Medical University Shijitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients suspectious of vascular diseases who would be performed CT angiography examination; (2) Written informed consent would be confirmed; (3) No history of allergy; (4) No history of cardiac and renal dysfunction.

Exclusion criteria

Exclusion criteria: (1) Patients with the History of alletrgic reaction to contrast media; (2) Patients with renal insufficiency (eGFR < 60 mL/min); (3) Patients who refused to provide informed consent for MDCT; (4) Patients with manifested thyrotoxicosis; (5) Patients with contraindications to any contrast media used in this study.

Design outcomes

Primary

MeasureTime frame
CT value;signal to noise ratio;contrast to noise ratio;—

Contacts

Public ContactRengui Wang

Capital Medical University Shijitan Hospital

renguiwang@aliyun.com+86 13911870396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026